ZYBERNO
Stock Report
Updated Sep 1, 2026

Aditxt, Inc. (ADTX)

Healthcare • NASDAQ

$0.01

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
7.0/100
POOR BUSINESS
Aditxt, Inc. (ADTX) scores 7/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (-573,535.9%)
Return on Capital (Capital Efficiency):CRITICAL (-100.8%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Aditxt, Inc. (ADTX) stock report — Zyberno Score 7/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.01
Market Cap:$7.48M

Valuation Multiples (2)

P/S Ratio:2,342.67x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$16.06M
B. Profitability Assessment

Return Metrics (4)

ROA:-284.8%
Reinvestment Rate:1.9%
Fundamental Growth Rate (g):-1.9%

Margin Analysis (3)

Operating Margin Ttm:-573,535.9%
Net Margin Ttm:-1,669,448.1%
Ebitda Margin:-565,569.2%

TTM Performance (3)

Gross Margin Ttm:17.2%
Operating Margin Ttm:-573,535.9%
Net Margin Ttm:-1,669,448.1%

Yield Metrics (2)

Earnings Yield:-$84.18M
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-816.3%
Latest Earnings Filed:2026-05-20

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-50.0%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.06x
Quick Ratio:0.05x
Cash Ratio:0.02x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-35.53x
Times Interest Earned:-35.53

Capital Structure (4)

Working Capital:-12,491,562.00
Cash And Cash Equivalents:268,852.00
Long Term Debt:$927.46K
Net Debt:$8.58M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $3.20K
Linear Growth: -50.0%
📊 Click to view full ADTX Revenue analysis & methodology →
Cost Of Revenue Ttm:$11.48K

Profitability Breakdown (2)

Gross profit TTM: $551.00
Linear Growth: -50.0%
📊 Click to view full ADTX Gross Profit analysis & methodology →
-$18.32M

Bottom Line Performance (3)

-$53.34M
Income Before Tax:-$53.02M
Ebitda Ttm:-18,069,935.00

Operating Expenses (5)

Operating Expenses:18,327,324.00
R And D Expense:3,032,011.00
Sga Expense:14,944,237.00
Income Tax Expense:$0.00
Interest Expense:550,793.00

Expense Ratios (3)

R And D To Revenue Percentage:713,414.4%
Sga To Revenue Percentage:3,516,291.1%
Ebitda Margin:-565,569.2%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$13.91M
Current Assets:$850.01K
Ppe Net:2,970,345.00
Goodwill:537,383.00
Intangible Assets:$1.94K

Liability Structure (4)

Total Liabilities:49,081,198.00
Current Liabilities:13,341,573.00
Long Term Debt:$927.46K
Short Term Debt:$7.92M

Equity & Capital (3)

Equity:-$35.17M
Retained Earnings:-$225.76M
Common Stock:1,000,000,000.00

Working Capital Items (3)

Accounts Receivable:11,974.00
Inventory:128,366.00
Accounts Payable:7,728,747.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

-$18.55M-$25.70M

Investment Activities (1)

Investing Cash Flow:-$10.38K

Financing Activities (3)

Financing Cash Flow:$1.66M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:254,537.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-1,936.20
-$1.94K
Earnings Per Share Ttm:-$0.05

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.00
Operating Cash Flow Per Share:-$0.03

Book Value & Capital (2)

Book Value Per Share:-$0.04
Cash Per Share:0.00

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.00x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:0.27x
Days Sales Outstanding Ttm:1,367.92

Inventory Management (2)

Inventory Turnover Ttm:0.09x
Days Inventory Outstanding Ttm:4,079.90

Payables & Cash Cycle (2)

Days Payable Outstanding:245,645.48
Cash Conversion Cycle:-240,197.65
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:20.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:1.9%
Fundamental Growth Rate (g):-1.9%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-50.0%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):-50.0%
Book Value Growth Rate (Linear):51.7%
C. Company Profile & Context

Corporate Information (6)

Symbol:ADTX
Company Name:Aditxt, Inc.
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:997.98M
Shares Outstanding Basic:20.17K
Shares Outstanding Diluted:20.17K

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 23:52:04 UTC
Data Timestamp:2026-08-22T21:40:27.601175
Scroll to Top